Bio-Rad Laboratories Inc (BIO)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 275,170 314,561 341,044 330,365 390,701 411,580 413,427 444,027 475,106 463,418 527,426 531,991 489,430 557,690 510,486 437,446 410,957 294,920 242,780 247,428
Revenue (ttm) US$ in thousands 2,566,525 2,580,209 2,562,604 2,605,238 2,671,262 2,720,366 2,769,042 2,779,031 2,802,249 2,804,730 2,870,979 2,895,811 2,922,545 2,979,615 2,879,829 2,700,778 2,545,626 2,380,215 2,293,585 2,329,324
Operating profit margin 10.72% 12.19% 13.31% 12.68% 14.63% 15.13% 14.93% 15.98% 16.95% 16.52% 18.37% 18.37% 16.75% 18.72% 17.73% 16.20% 16.14% 12.39% 10.59% 10.62%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $275,170K ÷ $2,566,525K
= 10.72%

The operating profit margin of Bio-Rad Laboratories Inc has shown some fluctuations over the observed period. The margin started at around 10.62% in March 2020 and experienced a gradual increase, reaching its peak at 18.72% in September 2021. However, it slightly dipped in the following quarters before stabilizing around 16-18%. By December 2024, the operating profit margin decreased to 10.72%, indicating a lower level of profitability compared to previous periods. Overall, the company has demonstrated solid operational efficiency, maintaining healthy profit margins for most of the period despite some fluctuations.